The administration of some pharmaceuticals or pharmacies and its various studies are directed to some cases that tend to complicate further with COVID-19 contact.
Eduardo Najar
Agencia Latina de Noticias Medicina y Salud Pública
Colchicine is a pharmacy that has been used with the end to prevent inflammatory effects in some patients that present pathological determinants, this drug has been used as an alternative to avoid complications of this indulgence in the respiratory system or level system.
Recent records have shown that the administration of this pharmacy to 4000 patients who have been part of a study and project has yielded beneficial results, and that some suggest that the drug works in about 64 people, these dates will be more important sus enfermedades.
Patients who are beneficiaries
As valid, the study of some patients with certain affections can be benefited if treated in a manner similar to colchicine, then academics support that those individuals who are diabetic and in addition to their mayors can favor a drug and prevent it.
“The colchicine is not a treatment to generalize, but can be used to help well”, said pharmacist Jesús Sierra
Eric Topol is one of the most committed investigators and scientists of the firm that studies this and the results are a major advance for the medical community, in addition to the fact that colchicine is an economical drug and has great access.
Treatment against COVID-19
Although there is a great deal of advancement in immunization against the pathogen of the new coronavirus, there are many alternative respect for treatments, and the various clinical outcomes and presentations have been limited in the treatment of encephalopathic therapies and direct. For another case, colchicine is an alternative to avoid a very common repercussion in the COVID patient, inflammation.
“Colchicine is not a panacea, but you can alleviate the situation in hospitals,” said cardiologist Alberto Cecconi.
If new studies are being carried out where the use of colchicine will be the center of attention, then it will be used as an alternative to certain basic determinations and in this way it must be validated that type of nurses need to be treated in order to a patient who has contracted SARS-CoV-2 does not present chronic pathological rankings and avoids mortality rates due to various complications.